Skip to main content
. Author manuscript; available in PMC: 2015 Feb 5.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Oct 29;20(1):134–139. doi: 10.1158/1055-9965.EPI-10-0673

Table 2.

Proteins identified in at least three ovarian cancer studies as reported by Kulasingam, Pavlou, and Diamandis (21) and have known ratios of one year hormone therapy compared to baseline.

Protein Log2 Ratio (1-Year HT/Baseline) P-Value
A2M 0.07 0.13
C3 0.13 0.0011
CFB 0.18 2.86E-05
CFI 0.092 0.0059
CLU 0.087 0.00094
COL1A1 -0.77 6.80E-05
FBLN1 -0.032 1.00
GRN 0.068 0.42
IGFBP2 -0.34 0.025
IGFBP4 0.35 0.010
LGALS1 0.21 0.09
LTBP1 -0.10 0.16
NPC2 0.03 0.29
PROS1 -0.11 0.07
SERPING1 0.47 0.012
TGFBI 0.31 0.0035
THBS1 0.23 0.24
VASN -0.39 0.0044
VTN 0.67 8.31E-09
WFDC2 -0.055 0.97